New eczema drug tested for safety with birth control and other meds
NCT ID NCT07190430
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 29 times
Summary
This study looks at how a new medicine for atopic dermatitis (eczema) called PF-08049820 affects the way other drugs work in the body. It involves 16 healthy adult women who will take the new medicine along with birth control pills, a sedative, and a blood thinner. The goal is to see if PF-08049820 changes how these drugs are processed, which will help plan future larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.